Full Press Release Details
NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street Capital Markets. Information for each can be found below:
Event:H.C. Wainwright 27thAnnual Global Investment ConferenceDate:September 8 – 9, 2025Location:In-person at the Lotte New York Palace Hotel and virtualFormat:Company presentation on Monday, September 8 at 5:00 pm ET, and one-on-one meetingsLink to live and replay:Click here
Event:Lake Street Capital Markets 9th Annual Best Ideas Growth Conference (BIG9)Date:September 11, 2025Location:In-person at the Yale Club of New York CityFormat:One-on-one meetingsInvestors wishing to participate are encouraged to reach out to their H.C. Wainwright or Lake Street sales representatives.
About Insight Molecular Diagnostics, Inc.Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visithttps://investors.Insight Molecular Diagnostics.com/for more information.
GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.
Investor Contact:
Doug FarrellLifeSci Advisors LLCdfarrell@lifesciadvisors.com